← Product Code [GNH](/submissions/MI/subpart-d%E2%80%94serological-reagents/GNH) · K842660

# ANTI-SCHISTOSOMA SPECIES KIT (K842660)

_Amico Lab, Inc. · GNH · Oct 30, 1984 · Microbiology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/IM/subpart-d%E2%80%94serological-reagents/GNH/K842660

## Device Facts

- **Applicant:** Amico Lab, Inc.
- **Product Code:** [GNH](/submissions/MI/subpart-d%E2%80%94serological-reagents/GNH.md)
- **Decision Date:** Oct 30, 1984
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 866.3600
- **Device Class:** Class 1
- **Review Panel:** Microbiology

## Regulatory Identification

Schistosoma spp. serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to Schistosoma spp. in serum. The identification aids in the diagnosis of schistosomiasis caused by parasitic flatworms of the genus Schistosoma. Schistosomiasis is characterized by a variety of acute and chronic infections. Acute infection is marked by fever, allergic symptoms, and diarrhea. Chronic effects are usually severe and are caused by fibrous degeneration of tissue around deposited eggs of the parasite in the liver, lungs, and central nervous system. Schistosomes can also cause schistosome dermatitis (e.g., swimmer's itch), a skin disease marked by intense itching.

---

**Source:** [https://fda.innolitics.com/submissions/IM/subpart-d%E2%80%94serological-reagents/GNH/K842660](https://fda.innolitics.com/submissions/IM/subpart-d%E2%80%94serological-reagents/GNH/K842660)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com